AstraZeneca to pull breast cancer and endometriosis drug Zoladex from Australian market in November

AstraZeneca is removing the breast cancer and endometriosis drug Zoladex from Australia's Pharmaceutical Benefits Scheme (PBS) and private market starting November, potentially leaving thousands of women without access to this vital treatment. Existing patients will have an addit